Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-15-003527
Filing Date
2015-06-19
Accepted
2015-06-19 16:31:17
Documents
1
Period of Report
2015-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT gff4_tarnow061915.html 4  
1 OWNERSHIP DOCUMENT gff4_tarnow061915.xml 4 5765
  Complete submission text file 0001171843-15-003527.txt   6995
Mailing Address
Business Address
TARNOW MICHAEL M (Reporting) CIK: 0001263647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 15942781

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations